PQQ Gold (Pyrroloquinoline quinone)

PQQ (Pyrroloquinoline quinone) is a redox cofactor that supports mitochondrial biogenesis and cellular energy production. The compound demonstrates neuroprotective properties through antioxidant mechanisms and mitochondrial function enhancement.

Origin & History

PQQ (pyrroloquinoline quinone) is a redox cofactor and antioxidant originally discovered in 1964 as a bacterial enzyme cofactor, with its structure identified in 1979 from methylotrophs and Acetobacter species. Commercial PQQ is produced via bacterial fermentation, purified by column chromatography, and crystallized as disodium salts (trihydrate or pentahydrate forms).

Historical & Cultural Context

PQQ has no documented traditional or historical use in any medicine system. It was first discovered in 1964 as a bacterial redox cofactor with no prior traditional applications noted.

Health Benefits

• Neuroprotection against toxicity from 6-hydroxydopamine and hypoxia/ischemia (demonstrated in preclinical models only)
• Potent antioxidant activity through scavenging superoxide and peroxynitrite radicals (in vitro evidence)
• Stimulation of cell growth and proliferation in culture (cell culture studies only)
• Inhibition of α-synuclein amyloid fibril formation (in vitro evidence)
• Protection against oxidative stress-induced cell damage (preclinical evidence only)

How It Works

PQQ functions as a redox cofactor that activates PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), promoting mitochondrial biogenesis and improving cellular energy metabolism. The compound scavenges superoxide and peroxynitrite radicals while protecting against oxidative stress through its quinone structure. PQQ also modulates CREB signaling pathways and supports neuronal survival by protecting against excitotoxicity.

Scientific Research

The research dossier explicitly notes the absence of human clinical trial data, RCTs, or meta-analyses for PQQ, with no PubMed PMIDs available for human studies. All current evidence comes from preclinical models including cell culture and animal studies demonstrating antioxidant and neuroprotective properties.

Clinical Summary

Current evidence for PQQ is primarily limited to preclinical studies and cell culture models. Animal studies demonstrate neuroprotection against 6-hydroxydopamine toxicity and hypoxia-ischemia injury in rodent models. In vitro research shows potent antioxidant activity and stimulation of cell growth and proliferation. Human clinical trials are limited, with most evidence coming from small pilot studies examining cognitive function and energy metabolism outcomes.

Nutritional Profile

PQQ (Pyrroloquinoline quinone) is a redox-active quinone cofactor and bioactive compound, not a traditional macronutrient or micronutrient. It is not a source of calories, protein, fat, carbohydrates, or fiber. Typical supplemental doses range from 10–20 mg per serving (standard commercial formulations), with research doses commonly at 20 mg/day in human studies. PQQ is classified as a quinone compound with the molecular formula C14H6N2O8 and molecular weight of 330.21 g/mol. It is found naturally in trace amounts in foods: highest concentrations reported in natto (~61 ng/g), green peppers (~28 ng/g), parsley (~17 ng/g), green tea (~4–5 ng/g), and human breast milk (~1.4–1.5 ng/mL). Dietary intake from food is estimated at approximately 0.1–1.0 mcg/day, far below supplemental levels. The 'Gold' designation in commercial formulations typically indicates a stabilized or enhanced-absorption form, often complexed with glycine or in disodium salt form (BioPQQ is a common branded ingredient produced via fermentation). Bioavailability: PQQ is well-absorbed orally in humans, with peak plasma concentrations reached within 1–2 hours post-ingestion; urinary recovery studies suggest meaningful systemic absorption at 20 mg doses. No significant vitamin, mineral, or fiber content is present in isolated PQQ supplement form.

Preparation & Dosage

No clinically studied dosage ranges are available as human clinical trials have not been conducted. Commercial forms include PQQ disodium trihydrate and pentahydrate, but therapeutic doses have not been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

CoQ10, Alpha-lipoic acid, Vitamin E, NAD+ precursors, Resveratrol

Safety & Interactions

PQQ appears generally well-tolerated in preliminary human studies, though comprehensive safety data is limited. No significant drug interactions have been documented, but theoretical interactions may exist with medications metabolized through oxidative pathways. Pregnant and breastfeeding women should avoid PQQ supplements due to insufficient safety data. Some users may experience mild gastrointestinal effects at higher doses above 20mg daily.